{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:26:03Z","timestamp":1777285563086,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jagp.2021.09.014","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T18:02:46Z","timestamp":1633629766000},"page":"541-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study"],"prefix":"10.1016","volume":"30","author":[{"given":"Rachel","family":"Ochs-Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Wajs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella J.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanne","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne C.","family":"Drevets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Sanacora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husseini","family":"Manji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaskaran B.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2021.09.014_bib0001","doi-asserted-by":"crossref","first-page":"M249","DOI":"10.1093\/gerona\/58.3.M249","article-title":"Depression in late life: review and commentary","volume":"58","author":"Blazer","year":"2003","journal-title":"J Gerontol Series A: Biol Sci Med Sci"},{"key":"10.1016\/j.jagp.2021.09.014_bib0002","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/gps.2485","article-title":"Remission in major depression: results from a geriatric primary care population","volume":"26","author":"Azar","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0003","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00019442-200305000-00011","article-title":"Partial response as a predictor of outcome in geriatric depression","volume":"11","author":"Steffens","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0004","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1176\/appi.ajp.2011.10081165","article-title":"A systematic review of treatments for refractory depression in older people","volume":"168","author":"Cooper","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1532-5415.2000.tb05005.x","article-title":"Update on electroconvulsive therapy (ECT) in older adult","volume":"48","author":"Kelly","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2021.09.014_bib0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/ajp.155.1.22","article-title":"Use of ECT for the inpatient treatment of recurrent major depression","volume":"155","author":"Olfson","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0007","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1590\/S0100-879X2005000900009","article-title":"Assessment of the cardiovascular effects of electroconvulsive therapy in individuals older than 50 years","volume":"38","author":"Takada","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jagp.2021.09.014_bib0008","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/npy.14.3","article-title":"Current electroconvulsive therapy practice and research in the geriatric population","volume":"4","author":"Kerner","year":"2014","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0009","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.pra.0000452569.92449.76","article-title":"The need to expand access to electroconvulsive therapy: a retrospective analysis of a new academic service","volume":"20","author":"Fernandez","year":"2014","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.jagp.2021.09.014_bib0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, Active-Controlled Study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2021.09.014_bib0011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jagp.2019.10.008","article-title":"Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3","volume":"28","author":"Ochs-Ross","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0012","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jagp.2021.09.014_bib0014","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, Open-Label Study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1903305","article-title":"Esketamine for treatment-resistant depression - first FDA-approved antidepressant in a new class","volume":"381","author":"Kim","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2021.09.014_bib0016","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/YIC.0b013e32832a8eb2","article-title":"Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?","volume":"24","author":"Montgomery","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.jagp.2021.09.014_bib0017","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2190\/T8EM-C8YH-373N-1UWD","article-title":"Assessing psychiatric impairment in primary care with the Sheehan Disability Scale","volume":"27","author":"Leon","year":"1997","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.jagp.2021.09.014_bib0018","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2021.09.014_bib0019","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jagp.2021.09.014_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.jagp.2021.09.014_bib0021","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.JGP.0000308881.22956.27","article-title":"Outcomes and predictors of late-life depression trajectories in older primary care patients","volume":"16","author":"Cui","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0022","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00019442-200501000-00007","article-title":"Impact of symptoms of generalized anxiety disorder on the course of late-life depression","volume":"13","author":"Steffens","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0023","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jagp.2021.09.014_bib0024","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0895-7061(97)00403-2","article-title":"The effects of talking, reading, and silence on the \u201cwhite coat\u201d phenomenon in hypertensive patients","volume":"11","author":"Le Pailleur","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jagp.2021.09.014_bib0025","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1161\/01.CIR.88.6.2794","article-title":"Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress","volume":"88","author":"Owens","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jagp.2021.09.014_bib0026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.maturitas.2013.02.009","article-title":"Risk factors for falls among older adults: a review of the literature","volume":"75","author":"Ambrose","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.jagp.2021.09.014_bib0027","unstructured":"Older Adult Falls Reported by State. 2020; https:\/\/www.cdc.gov\/falls\/data\/falls-by-state.html . Accessed September 01, 2021."},{"key":"10.1016\/j.jagp.2021.09.014_bib0028","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.clineuro.2009.12.015","article-title":"Falls and gait disorders in geriatric neurology","volume":"112","author":"Axer","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jagp.2021.09.014_bib0029","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1586\/ern.11.69","article-title":"The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?","volume":"11","author":"Segev-Jacubovski","year":"2011","journal-title":"Expert Rev Neurother"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121004917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121004917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:32:57Z","timestamp":1761021177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748121004917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1064748121004917"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2021.09.014","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2021.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of American Association for Geriatric Psychiatry.","name":"copyright","label":"Copyright"}]}}